Biblio

Export 240 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
K. Bourgade, Dupuis, G., Frost, E. H., and Fülöp, T., “Anti-Viral Properties of Amyloid-β Peptides.”, J Alzheimers Dis, vol. 54, no. 3, pp. 859-878, 2016.
K. Bourgade, Le Page, A., Bocti, C., Witkowski, J. M., Dupuis, G., Frost, E. H., and Fülöp, T., “Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1227-41, 2016.
A. Boulares, Fabre, C., Cherni, A., Jdidi, H., Chortane, S. Gaied, Trompetto, C., Puce, L., and Bragazzi, N. Luigi, “Effects of a Physical Activity Program that Incorporates Exercises Targeting Balance, Strength, and Proprioception on Cognitive Functions and Physical Performance in Old Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 96, no. 1, pp. 245-260, 2023.
S. Bouges, Fischer, B., Norton, D. L., Wyman, M. F., Lambrou, N., Zuelsdorff, M., Van Hulle, C. A., Ennis, G. E., James, T. T., Johnson, A. L., Chin, N., Carlsson, C. M., and Gleason, C. E., “Effect of Metabolic Syndrome Risk Factors on Processing Speed and Executive Function in Three Racialized Groups.”, J Alzheimers Dis, vol. 92, no. 1, pp. 285-294, 2023.
N. Boublay, Bouet, R., Dorey, J. - M., Padovan, C., Makaroff, Z., Federico, D., Gallice, I., Barrellon, M. - O., Robert, P., Moreaud, O., Rouch, I., and Krolak-Salmon, P., “Brain Volume Predicts Behavioral and Psychological Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1343-1353, 2020.
F. Botero-Rodríguez, Sastoque, A. Melisa Có, Escudero, J. Manuel San, and Santamaría-García, H., “Neuropsychiatric Symptoms in Patients with Neurocognitive Disorder and Their Performance Between Mild and Major Stages.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1735-1744, 2021.
B. O. A. Botchway, Moore, M. K., Akinleye, F. O., Iyer, I. C., and Fang, M., “Nutrition: Review on the Possible Treatment for Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 867-883, 2018.
G. Boström, Freyhult, E., Virhammar, J., Alcolea, D., Tumani, H., Otto, M., Brundin, R. - M., Kilander, L., Löwenmark, M., Giedraitis, V., Lleo, A., von Arnim, C. A. F., Kultima, K., and Ingelsson, M., “Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 81, no. 2, pp. 629-640, 2021.
B. Borroni, Benussi, A., Premi, E., Alberici, A., Marcello, E., Gardoni, F., Di Luca, M., and Padovani, A., “Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1113-1123, 2018.
E. Borland, Nägga, K., Nilsson, P. M., Minthon, L., Nilsson, E. D., and Palmqvist, S., “The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort.”, J Alzheimers Dis, vol. 59, no. 3, pp. 893-901, 2017.
H. Borghys, Van Broeck, B., Dhuyvetter, D., Jacobs, T., de Waepenaert, K., Erkens, T., Brooks, M., Thevarkunnel, S., and Araujo, J. A., “Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.”, J Alzheimers Dis, vol. 56, no. 2, pp. 763-774, 2017.
W. Vendramini Borelli, Augustin, M. Coutinho, de Oliveira, P. Bell Felix, Reggiani, L. Casagrande, Bandeira-de-Mello, R. Gorga, Schumacher-Schuh, A. Francisco, Chaves, M. Lorena Fag, and Castilhos, R. Machado, “Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1705-1712, 2021.
M. Germán Borda, Copete, A. María Aya, Tovar-Rios, D. Alejandro, Jaramillo-Jimenez, A., Giil, L. Melvær, Soennesyn, H., Gómez-Arteaga, C., Venegas-Sanabria, L. Carlos, Kristiansen, I., Chavarro-Carvajal, D. Andrés, Caicedo, S., Cano-Gutierrez, C. Alberto, Vik-Mo, A., and Aarsland, D., “Association of Malnutrition with Functional and Cognitive Trajectories in People Living with Dementia: A Five-Year Follow-Up Study.”, J Alzheimers Dis, vol. 79, no. 4, pp. 1713-1722, 2021.
C. Giuseppina Bonomi, Assogna, M., Di Donna, M. Gaia, Bernocchi, F., De Lucia, V., Nuccetelli, M., Fiorelli, D., Loizzo, S., Mercuri, N. Biagio, Koch, G., Martorana, A., and Motta, C., “Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1385-1397, 2023.
B. Bonnechère, Van Vooren, M., Bier, J. - C., De Breucker, S., Van Hove, O., Jan, S. Van Sint, Feipel, V., and Jansen, B., “The Use of Mobile Games to Assess Cognitive Function of Elderly with and without Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1285-1293, 2018.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., “Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
L. Bonanni, Franciotti, R., Martinotti, G., Vellante, F., Flacco, M. Elena, Di Giannantonio, M., Thomas, A., and Onofrj, M., “Post Traumatic Stress Disorder Heralding the Onset of Semantic Frontotemporal Dementia.”, J Alzheimers Dis, vol. 63, no. 1, pp. 203-215, 2018.
L. Bonanni, Franciotti, R., Nobili, F., Kramberger, M. G., Taylor, J. - P., Garcia-Ptacek, S., N Falasca, W., Famá, F., Cromarty, R., Onofrj, M., and Aarsland, D., “EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1649-1657, 2016.
M. Bolós, Llorens-Martín, M., Jurado-Arjona, J., Hernández, F., Rábano, A., and Avila, J., “Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo.”, J Alzheimers Dis, vol. 50, no. 1, pp. 77-87, 2016.
J. Carlos Cej Bolívar and Saladie, D. Gil, “Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.”, J Alzheimers Dis, vol. 53, no. 2, pp. 705-12, 2016.
J. Bohlken, Jacob, L., and Kostev, K., “Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany.”, J Alzheimers Dis, vol. 58, no. 1, pp. 37-44, 2017.
J. Bohlken and Kostev, K., “Relevance of Coded Prodromal Mild Cognitive Impairment in the Routine Treatment of Patients with Dementia in Germany.”, J Alzheimers Dis, vol. 65, no. 2, pp. 393-399, 2018.
J. Bohlken, Jacob, L., and Kostev, K., “Association Between the Use of Antihyperglycemic Drugs and Dementia Risk: A Case-Control Study.”, J Alzheimers Dis, vol. 66, no. 2, pp. 725-732, 2018.
J. Bohlken, Jacob, L., van den Bussche, H., and Kostev, K., “The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany.”, J Alzheimers Dis, vol. 64, no. 3, pp. 827-833, 2018.
A. Bogdan, Fabre, R., Desmidt, T., Golebiowski, J., Topin, J., Bethus, I., Hanon, O., Boutoleau-Bretonnière, C., Wagemann, N., Annweiler, C., Ousset, P. - J., Godefroy, O., Rouch, I., Paccalin, M., Sukhorukova, M., Gabelle, A., Robert, G., and David, R., “Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.”, J Alzheimers Dis, vol. 95, no. 2, pp. 415-426, 2023.

Pages